Treating Idiopathic Inflammatory Myopathies Related Reduced Bone Mineral Density With Denosumab or Zoledronic Acid

Conditions:   Idiopathic Inflammatory Myopathies;   Osteoporosis, Osteopenia Interventions:   Drug: Denosumab;   Drug: Zoledronic Acid Sponsors:   Kwong Wah Hospital;   Tung Wah Group of Hospitals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials